Based on spiral 3D tomography a large variety of applications have been developed during
the last decade to asses bone mineral density, bone macro and micro structure, and bone …

New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …

Context: Anorexia nervosa is complicated by severe bone loss and clinical fractures.
Mechanisms underlying bone loss in adults with anorexia nervosa include increased bone …

Postmenopausal osteoporosis is a common condition and is associated with increased risk
of fracture, including hip and vertebral fractures that in turn can have devastating …

Osteoporotic fractures, in particular hip and vertebral, are a major health burden worldwide.
The majority of these fractures occur in the elderly population, resulting in one of the most …

Bone turnover markers (BTMs) are divided into the markers of bone formation and those of
bone resorption. N-terminal collagen type I extension propeptide and serum C-terminal …

Major advances have occurred recently in the treatment of osteoporosis in recent years.
Most patients are currently treated with bisphosphonates, denosumab, raloxifene, or …

With the ageing population in most countries, disorders of bone and mineral metabolism are
becoming increasingly relevant to every day clinical practice. Consequently, the interest in …

As osteoporosis therapy options have expanded, and clinical guidelines have begun to
embrace the concept of limited treatment courses and “drug holidays,” the choices that …

Introduction: Osteoporosis is a chronic, skeletal disorder characterized by compromised
bone strength and increased risk of fractures, affecting up to 50% of postmenopausal …